REGENERON IMMUNE-COV Trademark Information

Trademark by Regeneron Pharmaceuticals, Inc.

Assays for SARS-CoV-2 virus research purposes

Medical diagnostic reagents and assays for identifying antibodies that neutralize the SARS-CoV-2 virus in patient blood samples

Custom design and development of chemical reagents and biochemical assays used for identifying antibodies that neutralize the SARS-CoV-2 virus in patient blood samples

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (001)
Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: REGENERON IMMUNE-COV
Status/Status Date:
NOTICE OF ALLOWANCE - ISSUED
11/3/2020
Serial Number: 88897919
Filing Date: 5/1/2020
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Assays for SARS-CoV-2 virus research purposes
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 9/8/2020
Last Applicant/Owner:
Regeneron Pharmaceuticals, Inc.
Tarrytown, NY 10591
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
OHLANDT, GREELEY, RUGGIERO & PERLE, LLP
ONE LANDMARK SQUARE
10TH FLOOR
STAMFORD, CT 06901
Current Status:
NOTICE OF ALLOWANCE - ISSUED
11/3/2020
Correspondent Search:
TERRENCE J. MCALLISTER is a correspondent of REGENERON IMMUNE-COV trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on